1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one has been researched along with trans-metanicotine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dar, MS; Smith, AD | 1 |
1 other study(ies) available for 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one and trans-metanicotine
Article | Year |
---|---|
Involvement of the alpha4beta2 nicotinic receptor subtype in nicotine-induced attenuation of delta9-THC cerebellar ataxia: role of cerebellar nitric oxide.
Topics: Animals; Area Under Curve; Cerebellar Ataxia; Cerebellum; Chalcones; Cyclic GMP; Dronabinol; Enzyme Inhibitors; Guanylate Cyclase; Male; Mice; Microinjections; Nicotine; Nicotinic Agonists; Nitric Oxide; Nitroprusside; Oxadiazoles; Postural Balance; Quinoxalines; Receptor, Cannabinoid, CB1; Receptors, Nicotinic; Stereotaxic Techniques | 2007 |